Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Diets on Response to Immune Checkpoint Inhibitors (ICIs) Therapy against Tumors
Xin Zhang, Huiqin Li, Xiupeng Lv, et al.
Life (2022) Vol. 12, Iss. 3, pp. 409-409
Open Access | Times Cited: 14

Showing 14 citing articles:

Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer
Irene Yu, Anthony Dakwar, Kazuaki Takabe
Cells (2023) Vol. 12, Iss. 2, pp. 258-258
Open Access | Times Cited: 21
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer
Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9406-9427
Open Access | Times Cited: 13
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
Maximilian Marhold, Simon Udovica, A. Halstead, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Age- and diet-instructed metabolic rewiring of the tumor–immune microenvironment
Ana Belén Plata-Gómez, Ping‐Chih Ho
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Closed Access
Nutritional strategies in oncology: The role of dietary patterns in modulating tumor progression and treatment response
Zeyao Wang, Xueying Wang, Zihan Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189322-189322
Closed Access
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond
Carlo Buonerba, Concetta Ingenito, Rossella Di Trolio, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 189-195
Open Access | Times Cited: 3
A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition
Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik‐Schmidt, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5369-5369
Open Access | Times Cited: 12
Pretreatment “prognostic nutritional index” as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis
Yifeng Shao, Wei Cao, Xinliang Gao, et al.
Medicine (2022) Vol. 101, Iss. 43, pp. e31113-e31113
Open Access | Times Cited: 11
Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy
Marin Golčić, Luka Simetić, Davorin Herceg, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3052-3052
Open Access | Times Cited: 6
Gut microbiome and cancer implications: Potential opportunities for fermented foods
Sylvia L. Crowder, Heather Jim, Stephanie Hogue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188897-188897
Closed Access | Times Cited: 5
What We Have Learned About Combining a Ketogenic Diet and Chemoimmunotherapy: A Case Report and Review of Literature
Daniel Sims, Agnes K. Liman, Victoria Leung, et al.
Federal practitioner (2023) Vol. 40, Iss. Suppl 3
Open Access | Times Cited: 1
Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors
Yuqian Wang, Lingeng Lu, Changquan Ling, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3984-3984
Open Access | Times Cited: 1
A Clinical Outcome of the anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition
Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik‐Schmidt, et al.
(2022)
Open Access | Times Cited: 2
Page 1

Scroll to top